People whose sleep brain waves register as biologically older than their actual age face a sharply elevated risk of ...

Medicine is rapidly evolving from statistical, evidence-based approaches to predictive, genotype-directed care, driven by ...

Abstract: Diabetes is a medical disorder disease that affects our body's food fuel systems. Eating food is converted to glucose and discharged to different body parts through blood and the pancreas ...

Predictive risk scores created using administrative claims and publicly available social determinants of health data strongly predicted severe diabetes complications for Maryland Medicare ...

Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...

And meta-regression further revealed an evaluation in predictive accuracy in prospective study designs (regression coefficient=2.289, P=0.001). Conclusions: Unlike previous narrative reviews, this ...

Abstract: Diabetes mellitus is a widespread chronic disease that requires continuous monitoring and personalized treatment. Traditional predictive analytics often rely on aggregating sensitive patient ...

Despite the established link between metabolic syndrome (MetS) and stroke incidence, the effects of dynamic and cumulative MetS scores on stroke risk among middle‐aged and older populations in China ...

Introduction Frailty is a common condition in older adults with diabetes, which significantly increases the risk of adverse health outcomes. Early identification of frailty in this population is ...

The healthcare industry is experiencing a significant shift, driven largely by the rise of artificial intelligence (AI) and its application in predictive analytics. This technology is revolutionizing ...

Diabetic peripheral neuropathy (DPN) is a common and debilitating complication of type 2 diabetes mellitus (T2DM), significantly impacting patients’ quality of life and increasing healthcare burdens.

• Based on product, the recombinant non-glycosylated proteins segment accounted for the largest revenue share for the U.S. biosimilars market in 2025. • The recombinant glycosylated proteins segment ...